Investing in Life Science Innovation

At Amzak Health we invest in first-in-class, best-in-class technologies in medtech and biotech.

Investing in Life Science Innovation

At Amzak Health we invest in first-in-class, best-in-class technologies in medtech and biotech.

About Amzak

More Than
Just Capital

We are venture investors and partners with our portfolio companies, working with management teams to achieve success.

About Amzak

More Than Just Capital

We are venture investors and partners with our portfolio companies, working with management teams to achieve success.

Our team

Partners of Choice

We are a small team of biotech and medtech investors with extensive investing and  operating experience and a track record of success.
We are a small team of biotech and medtech investors with extensive investing and  operating experience and a track record of success.

PORTFOLIO

Amzak Health is
Making a Difference

News

Sound Blade Medical Closes $16.5 Million Series A Financing to Advance the Development of Innovative Handheld Histotripsy Therapy

January 29, 2025

Medtronic inks distribution deal with Contego with option to buy firm

January 13, 2025

Hologic Completes Acquisition of Gynesonics, Inc.

January 6, 2025

category

Medtech

Status

Current

headquarters

Halifax, Nova Scotia

website

Sound Blade Medical

Sound Blade Medical is a medical device company that is developing handheld ultrasound-guided histotripsy technology to treat a wide range of conditions. Histotripsy is a non-invasive, non-thermal ablation technology to selectively destroy tissue with unparalleled precision.

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.

category

MEDTECH

status

Exited/Public

headquarters

Redwood City, California

website

Gynesonics

Gynesonics is a medical device company committed to advancing women’s health by developing transcervical, uterus-preserving, incisionless technologies for diagnostic and therapeutic applications. The company’s Sonata system is the world’s first and only intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms across a wide range of fibroid types, sizes, and uterine locations.